RBI
IONS icon

Raiffeisen Bank International’s Ionis Pharmaceuticals IONS Stock Holding History

Raiffeisen Bank International’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139K Hold
1,754
– – ﹤0.01% 537
2026
Q1 		$132K Hold
1,754
– – ﹤0.01% 506
2025
Q4 		$116K Hold
1,754
– – ﹤0.01% 500
2025
Q3 		$115K Buy
+1,754
New +$85.6K ﹤0.01% 501

Other funds holding IONS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Raiffeisen Bank International's IONS Position: Q2 2026 in Review

Raiffeisen Bank International reduced its Ionis Pharmaceuticals (IONS) stake by 2.8% in Q2 2026, selling an estimated $75.3K and leaving 35,000 shares worth $2.82M. The position accounts for 0.03% of the portfolio, ranked #253.

Raiffeisen Bank International first reported a position in IONS in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.21M in Q3 2025. 218 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Raiffeisen Bank International held 35,000 shares of Ionis Pharmaceuticals worth $2.82M as of Q2 2026.
  • Raiffeisen Bank International sold 1,000 Ionis Pharmaceuticals shares in Q2 2026, an estimated $75.3K.
  • Ionis Pharmaceuticals made up 0.03% of Raiffeisen Bank International's portfolio in Q2 2026, its #253 holding.
  • Raiffeisen Bank International first reported a position in Ionis Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Raiffeisen Bank International's Ionis Pharmaceuticals position peaked at $3.21M in Q3 2025.
  • 218 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.